About 5 results found for searched term "NMDA receptor antagonist 8" (0.128 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M42200 | NMDA receptor antagonist 8 | GluR |
| NMDA receptor antagonist 8 is GluN2B subunit-selective NMDA Receptor antagonist, with an Ki of 265 nM and an IC50 of 62 nM. | ||
| M3189 | TCN-201 | GluR |
| TCN201 | ||
| TCN 201 is a NMDA receptor antagonist for NR1/NR2A and NR1/NR2B with pIC50 of 6.8 and 4.3, respectively. | ||
| M28813 | Ro 25-6981 | GluR |
| Ro 25-6981 is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist. Ro 25-6981 shows anticonvulsant and anti-parkinsonian activity. Ro 25-6981 has the potential for the research of parkinson's disease (PD). | ||
| M30912 | Ro 25-6981 hydrochloride | GluR |
| Ro 25-6981 hydrochloride is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist. Ro 25-6981 hydrochloride shows anticonvulsant and anti-parkinsonian activity. Ro 25-6981 hydrochloride has the potential for the research of parkinson's disease (PD). | ||
| M56509 | Rislenemdaz | GluR |
| Rislenemdaz (CERC-301) is an orally bioavailable and selective N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
